Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclosporine Monitoring and Pharmacokinetics in Pediatrie Liver Transplant Patients.

Transplantation proceedings·2010
Same author

Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma.

Clinical pharmacology and therapeutics·2010
Same author

Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.

Clinical and experimental immunology·2006
Same author

Prevalence of group B streptococcal type VI capsular IgG antibodies in Japan.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2003
Same author

Early elevation of serum thrombopoietin levels and subsequent thrombocytosis in healthy preterm infants.

British journal of haematology·2002
Same author

Peroneal mononeuropathy in pediatric Hodgkin's disease.

Leukemia & lymphoma·2001

Related Experiment Video

Updated: May 30, 2026

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

Biomarkers in solid organ transplantation.

G Gieser1, H Harigaya, P M Colangelo

  • 1Office of Clinical Pharmacology, Center for Drug Evaluation, US Food and Drug Administration, Silver Spring, Maryland, USA. gerlie.gieser@fda.hhs.gov

Clinical Pharmacology and Therapeutics
|July 21, 2011
PubMed
Summary

This workshop focused on biomarkers for solid-organ transplantation. The goal was to share scientific findings and improve knowledge in this critical area of medical research.

More Related Videos

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Related Experiment Videos

Last Updated: May 30, 2026

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

Using a Chemical Biopsy for Graft Quality Assessment
05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Area of Science:

  • Pharmacology and Transplant Medicine
  • Biomarker Discovery and Validation

Background:

  • Solid-organ transplantation is a complex medical procedure with significant challenges.
  • Biomarkers play a crucial role in monitoring transplant health and predicting outcomes.

Purpose of the Study:

  • To enhance the collective knowledge on biomarkers in solid-organ transplantation.
  • To facilitate discussion and dissemination of current scientific findings.

Main Methods:

  • A workshop format was utilized, bringing together experts.
  • Presentations of scientific findings were central to the discussions.

Main Results:

  • Key scientific findings related to transplantation biomarkers were presented.
  • Discussions aimed to synthesize current knowledge and identify future directions.

Conclusions:

  • Enhanced understanding of biomarkers is vital for improving solid-organ transplant outcomes.
  • Continued research and collaboration are necessary to advance biomarker applications.